tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
vTv Therapeutics (VTVT)
NASDAQ:VTVT
US Market
VTVT
vTv Therapeutics
RESEARCH TOOLSreports

vTv Therapeutics (VTVT) Stock News & Sentiment

Compare
780 Followers
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
Premium
Ratings
vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target
5d ago
VTVT
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
Premium
Ratings
Paradigm-Shifting Potential in Type 1 Diabetes: vTv Therapeutics’ Cadisegliatin Supports Buy Rating and Significant Upside
14d ago
VTVT
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
Premium
Ratings
Positive Outlook for vTv Therapeutics: Buy Rating on Cadisegliatin’s Promising Phase 3 Trial and Market Potential
2M ago
VTVT
Promising Outlook for vTv Therapeutics: Buy Rating Affirmed Amidst Advancements in Type 1 Diabetes Treatment
Premium
Ratings
Promising Outlook for vTv Therapeutics: Buy Rating Affirmed Amidst Advancements in Type 1 Diabetes Treatment
2M ago
VTVT
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes
Premium
Company Announcements
vTv Therapeutics’ Promising Phase 3 Study on Cadisegliatin for Type 1 Diabetes
3M ago
VTVT
vTv Therapeutics to Join Morgan Stanley Conference
Premium
Company Announcements
vTv Therapeutics to Join Morgan Stanley Conference
4M ago
8K
VTVT
vTv Therapeutics Announces $80 Million Private Placement
Premium
Company Announcements
vTv Therapeutics Announces $80 Million Private Placement
5M ago
8K
VTVT
More VTVT News >

VTVT News on the Web

Why vTv Therapeutics Inc.’s (VTVT) Stock Is Down 5.28%
AAII
Neutral
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Up 10.85%
AAII
Neutral
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Up 5.64%
AAII
Neutral
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Down 6.30%
AAII
Neutral
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know
Zacks
Bullish
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Up 5.78%
AAII
Neutral
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Up 7.02%
AAII
Neutral
Why vTv Therapeutics Inc.’s (VTVT) Stock Is Up 8.48%
AAII
Neutral

News Score - Last 7 Days

Neutral
VTVT
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VTVT’s Media Buzz Sentiment?
3 articles about VTVT were published this week. In an average week, 1.25 articles are published.
    What is VTVT’s weekly average amount of articles?
    In an average week, 1.25 articles about VTVT are published.
      What is VTVT’s News Sentiment?
      50% of articles about VTVT were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        ALKSAlkermes
        AGENAgenus
        CAHCardinal Health
        BKDBrookdale Senior Living
        TGTXTG Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week